Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · January 05, 2025

Patient and Healthcare Provider Satisfaction, Acceptability, and Preferences Associated With Mirikizumab Administration for the Management of Ulcerative Colitis

Crohn's & Colitis 360

 

Additional Info

Disclosure statements are available on the authors' profiles:

Crohn's & Colitis 360
Patient and Healthcare Professional Satisfaction, Acceptability, and Preference Experiences With Mirikizumab Administration for Ulcerative Colitis: An International Survey
Crohns Colitis 360 2024 Oct 01;6(4)otae054, D Clemow, C Radawski, J Milata, K Alaka, TH Gibble, A Schaum, O Ezennia, N Martinez, T Szaloki, Y Ito, D Rodriguez, K Kirk

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading